日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Longitudinal gut microbiome dynamics are associated with clinical outcome and toxicity during ibrutinib therapy

肠道微生物群的纵向动态变化与伊布替尼治疗期间的临床结果和毒性相关

Morineau, Nadine; Tessoulin, Benoît; Guimard, Thomas; Papin, Mathilde; Roquilly, Antoine; Le Gouill, Steven; Montassier, Emmanuel

Late failure of aggressive B-cell lymphoma after CAR T-cell therapy: a LYSA study from the DESCAR-T registry

CAR-T细胞疗法后侵袭性B细胞淋巴瘤晚期治疗失败:来自DESCAR-T注册研究的LYSA研究

Erbella, Federico; Bachy, Emmanuel; Cartron, Guillaume; Gat, Elodie; Manson, Guillaume; Morschhauser, Franck; Gros, Francois-Xavier; Roulin, Louise; Tessoulin, Benoit; Bories, Pierre; Tournilhac, Olivier; Ricard, Laure; Guidez, Stéphanie; Choquet, Sylvain; Casasnovas, Rene-Olivier; Brisou, Gabriel; Campidelli, Arnaud; Castilla-Llorente, Cristina; Jardin, Fabrice; Gyan, Emmanuel; Guffroy, Blandine; Abraham, Julie; Decroocq, Justine; Chauchet, Adrien; Joris, Magalie; Claves, Fabien; Carras, Sylvain; Guillerm, Gaëlle; Loschi, Michaël; Hermine, Olivier; Taguy-Schimidt, Aline; Le Gouill, Steven; Houot, Roch; Di Blasi, Roberta

Pirtobrutinib, a highly selective, noncovalent (reversible) BTKi in R/R marginal zone lymphoma: phase 1/2 BRUIN study

Pirtobrutinib,一种高选择性、非共价(可逆)BTKi,用于治疗复发/难治性边缘区淋巴瘤:BRUIN 1/2期研究

Patel, Krish; Vose, Julie M; Nasta, Sunita D; Brown, Jennifer R; Maddocks, Kami J; Woyach, Jennifer A; Shah, Nirav N; Fakhri, Bita; Tessoulin, Benoit; Ma, Shuo; Jagadeesh, Deepa; Lech-Maranda, Ewa; Coombs, Catherine C; Patel, Manish R; Rhodes, Joanna M; Ujjani, Chaitra; Hoffmann, Marc S; Cheah, Chan Y; Munir, Talha; Lewis, David; Scarfò, Lydia; Eyre, Toby A; Alencar, Alvaro; Cohen, Jonathon B; Zelenetz, Andrew D; Tsai, Donald E; Li, Mei; Bian, Yuanyuan; Abada, Paolo; Balbas, Minna; Zinzani, Pier Luigi

Efficacy of anti-PD1 therapy in extranodal NK/T cell lymphoma: A matched cohort analysis from the LYSA

抗PD-1疗法治疗结外NK/T细胞淋巴瘤的疗效:来自LYSA研究的匹配队列分析

Marouf, Amira; Chaubard, Sammara; Liévin, Raphaël; Michot, Jean-Marie; Molinari, Nicolas; Rossignol, Julien; Cavalieri, Doriane; Golfier, Camille; Allangba, Olivier; Philippe, Laure; Tessoulin, Benoît; Chauchet, Adrien; Deau, Bénédicte; Oberic, Lucie; Vargaftig, Jacques; Moignet, Aline; Clavert, Aline; Dulery, Rémy; Brisou, Gabriel; Tardy, Stéphanie; Fataccioli, Virginie; Houot, Roch; Casasnovas, René O; Thieblemont, Catherine; Ghesquières, Hervé; Carras, Sylvain; Le Gouill, Steven; Cartron, Guillaume; Ribrag, Vincent; Cheminant, Morgane; Marçais, Ambroise; Suarez, Felipe; Marabelle, Aurélien; Tournilhac, Olivier; Damaj, Gandhi; Gaulard, Philippe; De Leval, Laurence; Lemonnier, François; Bachy, Emmanuel; Chevret, Sylvie; Hermine, Olivier; Couronné, Lucile; Jaccard, Arnaud

Validation of POD24 as a robust early clinical indicator of poor survival in mantle cell lymphoma from 1280 patients on clinical trials, a LYSA study

LYSA 研究通过对 1280 例参与临床试验的套细胞淋巴瘤患者进行分析,验证了 POD24 作为套细胞淋巴瘤早期预后不良的可靠临床指标的有效性。

Sarkozy, Clémentine; Chartier, Loïc; Ribrag, Vincent; Gressin, Remy; Geisler, Christian H; Kluin-Nelemans, Hanneke C; Thieblemont, Catherine; Morschhauser, Franck; Lemonnier, François; Safar, Violaine; Tessoulin, Benoît; Oberic, Lucie; Damaj, Ghandi; Ghesquières, Hervé; Bouabdallah, Krimo; Casasnovas, René Olivier; Houot, Roch; Klapper, Wolfram; Burroni, Barbara; Pott, Christiane; Delfau-Larue, Marie-Hélène; Macintyre, Elizabeth; Callanan, Mary; Jerkeman, Mats; Unterhalt, Michael; Hoster, Eva; Dreyling, Martin; Le Gouill, Steven; Hermine, Olivier; Cheminant, Morgane

Synthetic control arm from mixed clinical trials and real-world data from the LYSA group for untreated diffuse large B-cell lymphoma patients aged over 80 years: a bona fide strategy for innovative clinical trials

来自LYSA研究组的混合临床试验和真实世界数据的合成对照组,适用于80岁以上未经治疗的弥漫性大B细胞淋巴瘤患者:一项切实可行的创新临床试验策略

Letailleur, Valentin; Chaillol, Isabelle; Cherblanc, Fanny; Ghesquières, Hervé; Peyrade, Frédéric; Guidez, Stéphanie; Bijou, Fontanet; Sesques, Pierre; Rossi, Cédric; Fornecker, Luc-Matthieu; Fouillet, Ludovic; Carras, Sylvain; Chartier, Loïc; Belot, Aurélien; Oberic, Lucie; Jardin, Fabrice; Tessoulin, Benoit

Erratum to: Bendamustine and rituximab as first-line treatment for symptomatic splenic marginal zone lymphoma: long-term outcome and impact of early unmeasurable minimal residual disease attainment from the BRISMA/IELSG36 phase II study

更正:苯达莫司汀和利妥昔单抗作为症状性脾边缘区淋巴瘤的一线治疗:BRISMA/IELSG36 II期研究的长期疗效和早期不可测量微小残留病灶达到的影响

Iannitto, Emilio; Ferrero, Simone; Bommier, Côme; Drandi, Daniela; Ferrante, Martina; Bouabdallah, Krimo; Carras, Sylvain; Gini, Guido; Camus, Vincent; Mancuso, Salvatrice; Marcheselli, Luigi; Ferrari, Angela; Merli, Michele; Tessoulin, Benoit; Stelitano, Caterina; Beldjord, Kheira; Roti, Giovanni; Jardin, Fabrice; Castagnari, Barbara; Palombi, Francesca; Baseggio, Lucile; Traverse-Glehen, Alexandra; Tripodo, Claudio; Liberati, Anna Marina; Parolini, Margherita; Usai, Sara; Patti, Caterina; Federico, Massimo; Musso, Maurizio; Ladetto, Marco; Zucca, Emanuele; Thieblemont, Catherine

Respiratory management of critically ill pneumocystis pneumonia patients: a multicenter retrospective study

危重症肺孢子菌肺炎患者的呼吸管理:一项多中心回顾性研究

Reizine, Florian; Stiegler, Vicky; Lécuyer, Romain; Tessoulin, Benoit; Gallais, Marie; Camou, Fabrice; Morio, Florent; Cady, Anne; Gabriel, Frederic; Canet, Emmanuel; Raffi, François; Boutoille, David; Issa, Nahéma; Gaborit, Benjamin

Response to "high-flow nasal cannula and intubation risk in severe PjP: methodological and clinical perspectives"

对“重症 PjP 患者使用高流量鼻导管和插管的风险:方法学和临床视角”的回应

Reizine, Florian; Stiegler, Vicky; Tessoulin, Benoit; Issa, Nahema; Gaborit, Benjamin

Selective pharmacologic targeting of CTPS1 shows single-agent activity and synergizes with BCL2 inhibition in aggressive mantle cell lymphoma

选择性靶向CTPS1的药物治疗显示出单药活性,并且与BCL2抑制剂在侵袭性套细胞淋巴瘤中具有协同作用。

Durand, Romane; Bellanger, Céline; Kervoëlen, Charlotte; Tessoulin, Benoit; Dousset, Christelle; Menoret, Emmanuelle; Asnagli, Hélène; Parker, Andrew; Beer, Philip; Pellat-Deceunynck, Catherine; Chiron, David